PennyPerformers.com: "Penny Stocks that Perform" picks are: ATOG, GGLB, PVCT, UNDT, XSNX

Nov 25, 2008 (M2 PRESSWIRE via COMTEX) -- XSNX | Quote | Chart | News | PowerRating -- Pennyperformers.com "Penny Stocks that Perform" picks are: Atlas Oil and Gas, Inc. (OTCBB: ATOG), Green Globe International, Inc. (OTCBB: GGLB), Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), Universal Detection Technology (OTCBB: UNDT/FRANKFURT: PO8), XsunX, Inc. (OTCBB: XSNX)...and Proudly Introducing Proprietary Push Technology (PPT).

The Newest and Revolutionary Technology for Increasing Investor Visability.

REAL Awareness for REAL Companies.

Click below for a full demonstration.

http://newmediaadvisors.info/newmedia.swf

Sign-up for our FREE Stock Alerts AND NEWSLETTER at www.pennyperformers.com

Nov 25, 2008 -- Atlas Oil and Gas, Inc. (OTCBB: ATOG | Quote | Chart | News | PowerRating) announced the results today from its third well in its 8 well project located near the Arkansas River in Pawnee County, Oklahoma. The first well that was put into production had an initial rate of about 20 barrels of oil per day (BOPD) from a shallow zone at 1550'. The second well went on pump and is on its way to returning to its initial rate of about 40-50 BOPD.

Recently, the third well drilled was put back into production after being down for over a week for servicing. The well had initial recovery rates of between 3 and 4 barrels of oil per hour when it was first swabbed. After the acid treatment, the well was put on pump to recover the water from the acid treatment. Due to not having a large enough pump on the motor, the well has struggled to get "ahead of the water," a situation where water from the stimulation treatment pushes the oil up above the perforations so that mostly water comes into the tubing and up the well bore.

The gas in this well that is used to run the gas driven motor is also wet and so the motor has been on and off as it periodically cannot run off of the gas. This makes it difficult to get a steady, consistent fluid recovery drive. Nevertheless, in one 24-hour period, this well did put over 24 barrels of oil into the tanks despite still recovering oil from the stimulation treatment.

The operator for the project believes the production rate for all three of these wells will continue to increase once electricity is run to the lease and larger, more powerful electric motors are installed. These larger motors will enable the wells to generate a larger stroke and thereby lift more oil out from each of the wells.

"Like the third well drilled that went on pump a couple of days ago, this well has all of the signs of being a very good producer," said Dan Motsinger, President of Atlas Oil and Gas. "Once electric is run on this lease, we will be able to put everything on a normal production schedule with more standard sized motors for the level of fluid recovery we need. Nevertheless, again we have a well with several zones that can be produced and an initial recovery rate in the 2-3 barrels of oil range. We are still confident that we can get back to that initial rate, so we are quite pleased with results thus far."

This well was drilled to a depth of 2907' and had commercially viable amounts of oil and gas in about 4 different formations. The well was first perforated and acidized in the Bartlesville from 2500' to 2516' and after being perforated flowed naturally about 3-4 barrels of oil per hour.

About Atlas Oil & Gas, Inc.

Atlas Oil & Gas, Inc. is focused on developing shallow natural gas and oil wells in Northeastern Oklahoma. Atlas is an independent energy development firm primarily engaged in the exploration, development, and production of oil and natural gas. The company relies upon its industry partners, well operators, third party geologists, industry consultants, petroleum engineers, and financial analysts whose combined industry experience is essential to the success of each project. With the growing demand on oil and natural gas in the United States, Atlas will focus its resources on accomplishing its goal of successful well creation and distribution.

Nov 25, 2008 -- Green Globe International, Inc. (OTCBB: GGLB), the worldwide owner of the Green Globe brand, the premier international green brand for travel and tourism, today announced an agreement with the World Youth Student and Educational Travel Confederation (WYSETC) for collaboration in a number of areas that will introduce the Green Globe sustainability and carbon neutrality programs to a new generation of travelers.

The agreement outlines several areas of collaboration that will bring Green Globe's programs for the travel and tourism sector to WYSETC members, which includes a global community of youth travel, student travel and international education specialists. With a network of 5,000 locations in 118 countries, Confederation members provide international travel and educational experiences for more than 10 million students.

Areas of collaboration between Green Globe International and WYSETC include the implementation of Green Globe programs, in partnership with MCI, to make WYSETC Congress events carbon neutral; work to measure the Confederation's carbon footprint through Green Globe and affiliate programs; secure the support and participation of Confederation members around the world for the Green Globe program; offer Green Globe certain program packages to Confederation members at discounted rates; and develop targeted promotions and collateral material for the Green Globe program to WYSETC members, delegates and youth travelers worldwide.

"The youth travel market is clearly immense, and the World Youth Student and Educational Travel Confederation is extremely well connected to this global community," commented Steven R. Peacock, CEO and managing director of Green Globe International. "We are pleased to have the opportunity to work with the Confederation to spread awareness of the brand in the youth markets, as well as to implement Green Globe programs in specific applications related to the Confederation and its worldwide stakeholders."

Green Globe's standards for sustainable tourism practice are currently used across nearly 50 countries by both tourism businesses and communities.

The Green Globe brand and program, which traces its roots back to the United Nations Rio de Janeiro Earth Summit in 1992, where 182 Heads of State endorsed the Agenda 21 principles of Sustainable Development, has primarily been used in the travel and tourism industry but is now being expanded to include a growing number of environmentally responsible businesses in a variety of market sectors. The Green Globe brand is an ideal symbol for the world's increasing awareness of environmental responsibility and response to global climate change.

Green Globe International, an affiliate member of the United Nations World Tourism Organization (UNWTO), has endorsed the efforts of the United Nations Foundation, Rainforest Alliance, the United Nations Environment Programme (UNEP) and the UNWTO in launching the Global Sustainable Tourism Criteria (GSTC).

Green Globe International encourages all shareholders and others interested in following the progress of the company to subscribe to receive email alerts whenever new information is made public. To subscribe, please visit http://www.greenglobeint.com/stayconnected/email/.

About the World Youth Student and Educational Travel Confederation

The World Youth Student & Educational Travel Confederation is a dynamic, professionally managed not-for-profit organization, comprising over 550 members, representing the global community of youth travel, student travel and international education specialists. With a network of 5000 locations in 118 countries, Confederation members provide international travel and educational experiences for more than 10 million students and youth each year. The World Youth Student & Educational (WYSE) Travel Confederation was founded in 2006 with the merger of the Federation of International Youth Travel Organisations (FIYTO) and the International Student Travel Confederation (ISTC).

About Green Globe International, Inc.

Green Globe International, Inc. is the majority owner of Green Globe, Ltd., a British company that owns the Green Globe brand, the premier international brand for sustainable travel, tourism and related green businesses. Green Globe's worldwide network extends across nearly 50 countries. Green Globe International has been admitted as an affiliate member of the United Nations World Tourism Organization. The World Travel & Tourism Council (WTTC), the business leaders' forum for the travel and tourism industry, is a 5% common stock owner of Green Globe International.

Nov 25, 2008 -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, announced today that the first fifty percent (40 of 80) of melanoma subjects have been treated in its Phase 2 clinical trial of PV-10. Evaluation of new subjects continues at the trial's active centers in Adelaide, Brisbane and Sydney, Australia, as well as at M.D. Anderson, St. Luke's and the California Pacific Medical Center in the United States. The 40th subject was treated at the Royal Adelaide Hospital in Australia.

"Enrollment of the fortieth subject represents another significant milestone for Provectus Pharmaceuticals. With fifty percent of the subjects in the Phase 2 melanoma clinical trial already treated, we can continue to gather the data necessary to explore regulatory approval," said Craig Dees, Ph.D., CEO of Provectus. "With the recent addition of several more centers to the study we expect enrollment of the second half of subjects to continue at an accelerated pace."

Dees added, "As noted by Professor John Thompson, MD during his presentation at the "Perspectives in Melanoma XII" conference in The Hague, initial safety results from our expanded Phase 2 clinical trial of PV-10 for metastatic melanoma are also consistent with the Phase 1 safety profile. With the opportunity to treat lesions more than once in the Phase 2 study, we expect to improve upon the exceptional response noted in Phase 1. As we gather the results of the Phase 2 findings from these 40 subjects, our clinical trials team and respective regulatory authorities will consult to evaluate the potential for accelerated approval."

A further update on the study status is planned for the Sixth International Symposium on Melanoma, in mid-March 2009 in New York City. Safety data from the first 40 subjects, and interim efficacy data from the first 20 subjects, it expected to be presented at this meeting.

Provectus Pharmaceuticals' PV-10 has been granted orphan drug designation from the FDA for its metastatic melanoma indication. Provectus began phase 2 testing of PV-10 in late 2007, aiming to assess PV-10 chemoablation in 80 subjects with Stage III or IV metastatic melanoma, and announced in July that it had reached the first interim study milestone with the twentieth subject treated. According to the American Cancer Society, more than 62,000 people are expected to be diagnosed in the US in 2008 with melanoma, the most serious form of skin cancer, leading to over 8,000 deaths this year.

About Provectus Pharmaceuticals, Inc.

Provectus Pharmaceuticals is a development stage company that specializes in oncology and dermatology therapies that are safer, more effective, less invasive and more economical than conventional therapies. Provectus is currently conducting Phase 2 clinical trials of its proprietary drugs PV-10 as a therapy for metastatic melanoma and PH-10 as a topical treatment for psoriasis and atopic dermatitis. Information about these and the Company's other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. The Company has received orphan drug designation from the FDA for its melanoma indication. Complementing their suite of proprietary drugs, Provectus has developed a number of intellectual properties and technologies in the areas of imaging, medical devices and biotechnology.

Nov 25, 2008 -- Universal Detection Technology (OTCBB: UNDT/FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, today issued an analysis of the increased incidence of both community and hospital acquired methicillin-resistant Staphylococcus aureus (MRSA).

MRSA is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.

UNDT's Vital Oxide is truly the Ultimate Odorless Odor Eliminator. Vital Oxide eliminates odors on contact without leaving an odor of its own and actually kills 99.9% of bacteria it comes in contact with, including the MRSA (Super-Bug). Vital Oxide is not a "cocktail" of harmful chemicals that are not good for you or the environment.

The general population learned the extend of the MRSA threat last fall when the Centers for Disease Control and Prevention set off a media frenzy with its announcement that invasive MRSA infections claim at least 18,000 lives a year, more than AIDS. However, MRSA has been quietly killing for decades.

MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions. (CA)-MRSA has become a growing concern with athletes including the national football league (NFL). According to a recent report on the increased reports of MRSA in the NFL: "MRSA is getting nastier because there are now multiple strains of it and because football is a game where cuts are common. So-called community MRSA is caught in the locker room, then mixes with the nastier type in a hospital when you go in for treatment."

UNDT's line of anti-bacterial sprays have been specifically designed to be effective against MRSA. Studies on the product show that areas treated with the solution not only become disinfected, but also no new stains appear on the treated area for up to 7 days.

"The threat of Community MRSA is becoming more and more evident everyday and we have developed products to counter the threat," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer. "Every school and university needs to implement strict disinfection techniques to insure the safety of the students," he added.

Nov 25, 2008 -- XsunX, Inc. (OTCBB: XSNX), a solar technology company engaged in the build-out of its multi-megawatt thin film photovoltaic (TFPV) solar manufacturing facilities in Oregon, announced today that it had entered into a two-year supply contract for the sale of fifteen (15) megawatts of it ASI-120 TFPV solar modules to a full service solar power company specializing in commercial and solar farm projects located in the California and Hawaiian markets.

"We are pleased to announce this sales agreement to supply 15 megawatts of our ASI-120 TFPV solar modules," stated Tom Djokovich, CEO of XsunX. "This agreement represents approximately $37 million dollars in total contract value with an initial 5 megawatts valued at $13 million slated for delivery in calendar 2009, and the remaining 10 megawatt balance for delivery in calendar 2010. The recent passage of an eight year extension to the 30% Federal Investment Tax Credit is spurring renewed vigor in solar project demand and we are working to fill our projected production capacity over the next several years with additional purchase agreements," concluded Djokovich.

About PennyPerformers.com

PennyPerformers.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

Penny Performers email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Penny Performers Report home page at www.PennyPerformers.com and select the "join now" button.

Join us at www.PennyPerformers.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. PennyPerformers.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyPerformers.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. PennyPerformers.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), PennyPerformers.com is owned and operated by PennyPerformers.com. Neither PennyPerformers.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since PennyPerformers.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in PennyPerformers.com statements and opinions and such statements and opinions cannot be considered independent. PennyPerformers.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. PennyPerformers.com services are often paid for using free-trading shares. PennyPerformers.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: www.PennyPerformers.com/disclaimer.htm

CONTACT: Pennyperformers.com e-mail: info@pennyperformers.com WWW: hrtp://www.PennyPerformers.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index